Total Payments
$122,437
2024 Payments
$39,850
Companies
17
Transactions
171
Medicare Patients
1,034
Medicare Billing
$122,479
Payment Breakdown by Category
Other$93,975 (76.8%)
Travel$12,408 (10.1%)
Consulting$11,575 (9.5%)
Food & Beverage$4,381 (3.6%)
Education$97.78 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,925 | 43 | 53.0% |
| Honoraria | $29,050 | 17 | 23.7% |
| Travel and Lodging | $12,408 | 37 | 10.1% |
| Consulting Fee | $11,575 | 4 | 9.5% |
| Food and Beverage | $4,381 | 67 | 3.6% |
| Education | $97.78 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CALLIDITAS THERAPEUTICS US INC. | $40,495 | 46 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $34,646 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $26,414 | 29 | $0 (2024) |
| Travere Therapeutics, Inc. | $13,145 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,807 | 6 | $0 (2024) |
| Amgen Inc. | $263.58 | 3 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $182.04 | 2 | $0 (2019) |
| GENZYME CORPORATION | $116.95 | 1 | $0 (2018) |
| Mallinckrodt LLC | $100.12 | 1 | $0 (2018) |
| Vifor Pharma, Inc. | $98.31 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $39,850 | 61 | CALLIDITAS THERAPEUTICS US INC. ($19,824) |
| 2023 | $50,663 | 61 | Calliditas Therapeutics US Inc. ($20,672) |
| 2022 | $21,871 | 32 | Aurinia Pharma U.S., Inc. ($19,547) |
| 2021 | $9,476 | 9 | GlaxoSmithKline, LLC. ($9,457) |
| 2019 | $202.45 | 3 | Otsuka America Pharmaceutical, Inc. ($182.04) |
| 2018 | $325.02 | 3 | GENZYME CORPORATION ($116.95) |
| 2017 | $49.12 | 2 | Amgen Inc. ($37.36) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $145.21 | General |
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $61.54 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: Nephrology | ||||||
| 12/10/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/09/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $800.00 | General |
| Category: Nephrology | ||||||
| 12/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $132.87 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/05/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $28.27 | General |
| 12/02/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| 11/19/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $400.00 | General |
| Category: Nephrology | ||||||
| 11/14/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 11/13/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $74.84 | General |
| Category: Nephrology | ||||||
| 11/13/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $37.37 | General |
| Category: Nephrology | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Immunology | ||||||
| 11/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $809.95 | General |
| Category: Nephrology | ||||||
| 11/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $772.24 | General |
| Category: Nephrology | ||||||
| 11/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Nephrology | ||||||
| 11/08/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $119.83 | General |
| 10/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Immunology | ||||||
| 10/25/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $48.31 | General |
| Category: Nephrology | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $126.86 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $66.76 | General |
| 10/15/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $114.50 | General |
| 10/11/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| 09/27/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $371.71 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 201 | 386 | $102,372 | $25,961 |
| 2022 | 7 | 234 | 399 | $104,529 | $26,938 |
| 2021 | 7 | 262 | 449 | $112,112 | $31,124 |
| 2020 | 10 | 337 | 567 | $137,281 | $38,456 |
Total Patients
1,034
Total Services
1,801
Medicare Billing
$122,479
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 49 | 171 | $37,728 | $10,384 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 59 | $22,024 | $4,685 | 21.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 40 | $13,348 | $3,738 | 28.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $13,168 | $3,473 | 26.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 16 | 33 | $6,973 | $1,822 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 34 | $8,981 | $1,811 | 20.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 12 | 15 | $150.00 | $48.10 | 32.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 91 | $26,748 | $7,340 | 27.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 49 | 118 | $24,341 | $6,600 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 43 | 72 | $26,440 | $5,979 | 22.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 36 | 38 | $14,842 | $4,062 | 27.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 22 | 27 | $5,634 | $1,556 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 24 | $6,234 | $1,304 | 20.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 21 | 29 | $290.00 | $96.21 | 33.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 71 | 147 | $29,547 | $8,368 | 28.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 65 | $24,050 | $6,135 | 25.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 65 | $18,720 | $5,303 | 28.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 42 | 43 | $16,383 | $4,641 | 28.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 34 | 78 | $15,912 | $4,546 | 28.6% |
| 90945 | Dialysis procedure including one evaluation | Facility | 2021 | 14 | 30 | $7,290 | $2,063 | 28.3% |
| 81002 | Urinalysis, manual test | Office | 2021 | 17 | 21 | $210.00 | $69.60 | 33.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 100 | 224 | $44,800 | $13,008 | 29.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 50 | 88 | $25,168 | $7,386 | 29.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 56 | 56 | $21,112 | $6,235 | 29.5% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 34 | 60 | $13,260 | $3,422 | 25.8% |
About Swati Arora
Swati Arora is a Nephrology healthcare provider based in Pittsburgh, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2009. The National Provider Identifier (NPI) number assigned to this provider is 1639304082.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Swati Arora has received a total of $122,437 in payments from pharmaceutical and medical device companies, with $39,850 received in 2024. These payments were reported across 171 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($64,925).
As a Medicare-enrolled provider, Arora has provided services to 1,034 Medicare beneficiaries, totaling 1,801 services with total Medicare billing of $122,479. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Pittsburgh, PA
- Active Since 05/28/2009
- Last Updated 10/01/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1639304082
Products in Payments
- TARPEYO (Drug) $40,495
- LUPKYNIS (Drug) $34,146
- BENLYSTA (Biological) $26,414
- Fabhalta (Drug) $1,227
- JYNARQUE (Drug) $120.84
- FABRAZYME (Drug) $116.95
- Parsabiv (Biological) $107.95
- ACTHAR (Biological) $100.12
- Veltassa (Drug) $98.31
- SAMSCA (Drug) $61.20
- JARDIANCE (Drug) $39.53
- FARXIGA (Drug) $35.49
- IBSRELA (Drug) $25.39
- Inrebic (Drug) $20.41
- OPDIVO (Biological) $18.80
- Yescarta (Drug) $18.04
- JANUVIA (Drug) $11.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Pittsburgh
Khaled Nashar, Md, MD
Nephrology — Payments: $133,158
Nephrology $133,158
Dr. Linda Fried, M.d, M.D
Nephrology — Payments: $88,123
Nephrology $88,123
Cary Shiwarski
Nephrology — Payments: $14,955
Nephrology $14,955
Dr. Paul Palevsky, M.d, M.D
Nephrology — Payments: $13,922
Nephrology $13,922
Dr. Linda Belayev, M.d, M.D
Nephrology — Payments: $12,553
Nephrology $12,553
Sandeep Sharma, Md, MD
Nephrology — Payments: $5,618
Nephrology $5,618